By Staff
Friday, April 19, 2024 12:30 AM
CHARENTON-LE-PONT, France—
EssilorLuxottica announced yesterday that consolidated revenue for the first quarter of 2024 was €6,335 million, representing a year-on-year increase of 5.5 percent at constant exchange rates compared with the first quarter of 2023. Francesco Milleri, chairman and CEO, and Paul du Saillant, deputy CEO at EssilorLuxottica commented, “We’re pleased to report another solid start to the year for the company, with every geography and business contributing to the positive performance.” The initial quarter of 2024 grew mid-single digit in line with the company’s long-term guidance.
By Staff
Friday, April 19, 2024 12:15 AM
NEW YORK—
Vision Monday will be publishing its signature
Annual Top 50 U.S. Optical Retailers Report in its upcoming June print/digital edition this year.
VM's annual
survey of regional and national retailers will collect and present sales and operations data for the calendar year ending Dec. 31, 2023. The deadline to submit information is April 26. "The Top 50 report and ranking will continue to examine U.S optical retail and ECP group revenues, and serves as a valuable resource to readers," said Anne Cooper, editorial director of
Vision Monday and
20/20.
By Staff
Thursday, April 18, 2024 12:24 AM
BATH, England—
Inspecs Group plc (LSE: SPEC), a global eyewear and lens design house and manufacturer, reported its 2023 full-year financial results. Group revenue for 2023 grew 1 percent to £203.3 million compared with £201.0 million in the same period last year. On a constant exchange rate basis, revenue decreased to £200.7 million (compared with £201.0 million in 2022). Gross profit for 2023 increased 4.7 percent year-over-year to £103.5 million. Cash generated from operations was £16.9 million, while net debt excluding leasing was £24.2 million.
By Staff
Wednesday, April 17, 2024 12:27 AM
NEW BRUNSWICK, N.J.—
Johnson & Johnson (NYSE: JNJ) has announced financial results for the first quarter of 2024, with reported sales growth of 2.3 percent to $21.4 billion, operational growth of 3.9 percent, and adjusted operational growth of 4.0 percent. Sales in the U.S. increased 7.8 percent for the first quarter. “Johnson & Johnson’s solid first quarter performance reflects our sharpened focus and the progress in our portfolio and pipeline,” said Joaquin Duato, chairman and chief executive officer. “Our impact across the full spectrum of health care is unique in our industry, and the milestones achieved this quarter reinforce our position as an innovation powerhouse.”
By Staff
Monday, April 15, 2024 12:15 AM
NEW YORK—
Vision Monday will be publishing its signature
Annual Top 50 U.S. Optical Retailers Report in its upcoming June print/digital edition this year.
VM's annual
survey will include regional and national retailers for the exclusive report.
By Staff
Wednesday, April 10, 2024 12:21 AM
CHARENTON-LE-PONT, France—Luxottica Japan, part of
EssilorLuxottica, closed the acquisition of Washin Optical Co., Ltd., a Japanese optical retailer with approximately 70 direct stores in the country, according to an announcement from EssilorLuxottica.
By Staff
Friday, April 5, 2024 12:24 AM
LAKE FOREST, Calif.—
STAAR Surgical Company, a developer, manufacturer and marketer of the EVO family of implantable collamer lenses for myopia, astigmatism and presbyopia, has announced that preliminary net sales for the first quarter are expected to be in excess of $77 million.
By Staff
Tuesday, April 2, 2024 12:27 AM
NEW YORK—
Vision Monday will be publishing its signature
Annual Top 50 U.S. Optical Retailers Report in its upcoming June print/digital edition this year. The industry's leading news platform is kicking off its annual
survey among regional and national retailers for the exclusive report, which will collect and present sales and operations data for the calendar year ending Dec. 31, 2023. "The Top 50 report and ranking will continue to examine U.S optical retail and ECP group revenues, and serves as a valuable resource to readers," said Anne Cooper, editorial director of
Vision Monday and
20/20.
By Staff
Thursday, March 28, 2024 12:24 AM
EMERYVILLE, Calif.—
NovaBay Pharmaceuticals, Inc. (NYSE American: NBY) reported financial results for the three and 12 months ended December 31, 2023.
By Staff
Wednesday, March 27, 2024 12:21 AM
LONGARONE and MILAN, Italy—On March 25, 2024, the board of directors of
Marcolin presented the draft of the Group’s separate and consolidated financial statements for the year ended December 31, 2023. Although the period was characterized by international geopolitical instability and logistical complexity, Marcolin was able to consolidate its performance in 2023.
By Staff
Tuesday, March 26, 2024 12:15 AM
MIAMI—
Innovative Eyewear Inc., a developer of smart eyewear under the Lucyd, Nautica, Eddie Bauer and Reebok brands, has announced that, for the year ended Dec. 31, 2023, the company's revenues were $1,152,479, an increase of approximately 75 percent as compared with revenues of $659,788 for the year ended Dec. 31, 2022.
By Staff
Friday, March 22, 2024 12:24 AM
NEW YORK—
Eyenovia, Inc. (NASDAQ: EYEN), a commercial-stage ophthalmic company, has announced its financial and operating results for the fourth quarter and full year ended December 31, 2023. For the fourth quarter of 2023, net loss was approximately $8.0 million compared with a net loss of $6.1 million for the fourth quarter of 2022. For the full-year 2023, net loss was approximately $27.3 million compared with a net loss of $28.0 million for the full year 2022.
By Staff
Thursday, March 21, 2024 12:24 AM
NASHVILLE, Tenn.—
Harrow (Nasdaq: HROW), a leading U.S. eyecare pharmaceutical company, announced results for the fourth quarter and year ended December 31, 2023. Revenues were $130.2 million for full-year 2023, an increase of 47 percent over 2022 revenues of $88.6 million. Adjusted EBITDA was $28.1 million, an increase of 116 percent over 2022 adjusted EBITDA of $13.0 million. The company also reported GAAP net loss of $24.4 million for 2023 compared with $14.1 million for the prior-year period.
By Staff
Friday, March 15, 2024 12:30 AM
PADUA, Italy—The board of directors of
Safilo Group S.p.A. (SFLG.MI) has approved the company’s consolidated financial statements for the year ended December 31, 2023, and examined the separate financial statements for the year ended December 31, 2023.
By Staff
Monday, March 4, 2024 12:15 AM
ALISO VIEJO, Calif.—
RxSight, Inc., an ophthalmic medical device company dedicated to providing customized vision to patients following cataract surgery, reported financial results for the three months and full year ending Dec. 31, 2023.